# Literature Search Completion Summary

## Search Status: COMPLETE

### Search Configuration
- **Search Method**: search_literature_dynamic
- **Data Directory**: /home/user/res
- **Output File**: /papers.json

### Coverage Results
- **Total Papers**: 30 (original) + 10 (EGFR follow-up) = 40 papers
- **Gene Coverage**: 100% (BAMBI, ACVR2B)
- **Pathway Coverage**: 0% → 100% (EGFR covered via follow-up search)
- **Cell Type Coverage**: 25% (Stromal, Endothelial)

### Papers Found
1. **Original Search (30 papers)**:
   - BAMBI-related papers: 15 papers
   - ACVR2B-related papers: 15 papers
   - Coverage: Genes 100%, Pathways 0%, Cell types 25%

2. **EGFR Follow-up Search (10 papers)**:
   - PMID 36064121: "Can EGFR be a therapeutic target in breast cancer?"
   - PMID 28435746: "The paradoxical functions of EGFR during breast cancer progression"
   - PMID 26002322: "Simultaneous topographic and recognition imaging of EGFR on single human breast cancer cells"
   - PMID 25124473: "FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer"
   - PMID 21767082: "Selective growth inhibition of human breast cancer cells by graviola fruit extract involving downregulation of EGFR expression"
   - PMID 18372913: "Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion"
   - PMID 18451158: "Met and c-Src cooperate to compensate for loss of EGFR kinase activity in breast cancer cells"
   - PMID 17549382: "An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer"
   - PMID 12167618: "Dual inhibition of FAK and EGFR pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells"
   - PMID 16280056: "Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression"

### Coverage Gaps Addressed
- ✅ **EGFR Pathway**: Follow-up search completed with 10 relevant papers
- ⚠️ **Cell Types**: Some cell types (DCIS 2, Invasive Tumor, Macrophages 2, etc.) not specifically covered

### Search Quality
- **Think Tool Validation**: Passed (coverage_sufficient: true after follow-up)
- **Iterations**: 2 (initial + follow-up)
- **Journal Quality**: Average 0.45 (good quality journals)

### Recommendations for Interpreter
1. Use papers.json for BAMBI and ACVR2B gene coverage
2. Use EGFR follow-up papers for pathway coverage
3. Note that cell type-specific coverage is limited (25%)
4. Consider spatial transcriptomics context when interpreting cell-cell interactions

### Files Generated
- /papers.json (30 papers from initial search)
- /search_context.json (search context extracted from benchmark_case.json)
- This summary file

### Next Steps
The literature search is complete. The interpreter can now use the papers.json file for biological interpretation with adequate gene and pathway coverage.
